πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 124 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6441019

Cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6436929

Cyclothiocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6423699

Combination therapies using benzimidazolones

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6417214

3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6417212

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6413952

Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating meta

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407101

Cyanopyrroles

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6399593

Cyclic regimens using cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6391907

Indoline derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6380207

Glucocortiocoid-selective antiinflammatory agents

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6380235

Benzimidazolones and analogues

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6369056

Cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6358948

Quinazolinone and benzoxazine derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6358947

Tetracyclic progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6355648

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6339098

2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jan 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6320074

Compounds having selective activity for retinoid X receptors, and means for modulation of

Ligand Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6319912

Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6316404

Treating NIDDM with RXR agonists

Ligand Pharmaceuticals Incorporated Β· Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6306851

Cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6228862

Treating NIDDM with RXR agonists

Ligand Pharmaceuticals Incorporated Β· Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired